ALX vs SRPT · P/E 63, rev $108.1M vs rev $1.13B
Alexanders Inc (ALX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Alexanders Inc (ALX) is a reit - retail company listed on NYSE.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported ALX revenue for 2026-06-30 was $108.1M. Net income was $160.0M. ALX currently screens at market cap $1.30B and trailing P/E 63.5.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
ALX currently screens at market cap $1.30B and trailing P/E 63.5. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ALX and SRPT stock pages for the full models.
Not investment advice.